Science References

  1. 1. Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
  2. 2. ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
  3. 3. Hoffmann D. 2003. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press.
  4. 4. Blumenthal M, Goldberg A, Brinckmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
  5. 5. Mills S, Bone K. 2000. Principles and Practice of Phytotherapy. Toronto (ON): Churchill Livingstone.
  6. 6. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmstrom C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic journal of psychiatry 2007;61(5):343-348.
  7. 7. EMA 2012: Committee on Herbal Medicinal Products (HMPC) Community herbal monograph on Rhodiola rosea L., rhizoma et radix Final. London (GB): European Medicines Agency, Science Medicines Health. http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2012/05/WC500127863.pdf
  8. 8. Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
  9. 9. Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester (VT): Healing Arts Press, 2007.
  10. 10. Pizzorno JE, Murray MT, editors. Textbook of Natural Medicine. Third edition, volume 1. St. Louis (MI): Churchill Livingstone Elsevier; 2006.
  11. 11. Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester (VT): Healing Arts Press, 2007.
  12. 12. Kim SH, Hyun SH, Choung SY. Antioxidant effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver of diabetic mice. Biofactors 2006;26(3): 209-219.
  13. 13. Skarpanska-Stejnborn A, Pilaczynska-Szczesniak L, Basta P, Deskur-Smielecka E. The influence of supplementation with Rhodiola rosea L. extract on selected redox parameters in professional rowers. International Journal of Sport Nutrition and Exercise Metabolism 2009; 19(2): 186-199.
  14. 14. BHP 1983: British Herbal Pharmacopoeia. Cowling (GB): British Herbal Medical Association; 1983.
  15. 15. Bradley PR, editor. 1992. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 1. Bournemouth (GB): British Herbal Medicine Association.
  16. 16. D’Angelo L, Grimaldi R, Caravaggi M, Marcoli M, Perucca E, Lecchini S, Frigo GM, Crema A. 1986. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers. Journal of Ethnopharmacology 16(1):15-22.
  17. 17. ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
  18. 18. Kennedy DO, Haskell CF, Wesnes KA, Scholey AB. 2004. Improved cognitive performance in human volunteers following administration of guarana (Paullinia cupana) extract: comparison and interaction with Panax ginseng. Pharmacology, Biochemistry and Behavior 79(3):401-411
  19. 19. Kennedy DO, Scholey AB, Wesnes KA. 2002. Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiology & Behavior 75(5):739-751
  20. 20. Kennedy DO, Scholey AB, Wesnes KA. 2001. Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers. Nutritional Neuroscience 4(4):295-310
  21. 21. Reay JL, Kennedy DO, Scholey AB. 2006. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained ‘mentally demanding’ tasks. Journal of Psychopharmacology 20(6):771-781.
  22. 22. Reay JL, Kennedy DO, Scholey AB. 2005. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology 19(4):357-365.
  23. 23. Scholey AB, Kennedy DO. 2002. Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Human Psychopharmacology 17(1):35-44.
  24. 24. Sorensen H, Sonne J. 1996. A double-masked study of the effects of ginseng on cognitive functions. Current Therapeutic Research 57(12):959-968.
  25. 25. Sünram-Lea SI, Birchall RJ, Wesnes KA, Petrini O. 2005. The effect of acute administration of 400 mg of Panax ginseng on cognitive performance and mood in healthy young volunteers. Current Topics in Nutraceutical Research 3(1):65-74.
  26. 26. ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.
  27. 27. Gross D, Shenkman Z, Bleiberg B, Dayan M, Gittelson M, Efrat R. 2002. Ginseng improves pulmonary functions and exercise capacity in patients with COPD. Monaldi Archives for Chest Disease 57(5-6):242-246.
  28. 28. Gross D, Krieger D, Efrat R, Dayan. 1995. Ginseng extract G115 for the treatment of chronic respiratory diseases. Schweiz Zschr Ganzheits Medizin 1:29-33
  29. 29. Kim SH, Park KS, Chang MJ, Sung JH. 2005. Effects of panax ginseng extract on exercise-induced oxidative stress. Journal of Sports Medicine and Physical Fitness 45(2):178-182.
  30. 30. Sotaniemi EA, Haapakoski E, Rautio A. 1995. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care 18(10):1373-1375.
  31. 31. WHO 1999: World Health Organization. WHO Monographs on Selected Medicinal Plants, Volume 1. Geneva (CH): World Health Organization; 1999.
  32. 32. Cieza A, Maier P, Pöppel E. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Archives of Medical Research 2003;34(5):373-381.
  33. 33. Kennedy DO, Scholey AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000;151(4):416-423.
  34. 34. Mix JA, Crews WD. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings. Human Psychopharmacology: Clinical and Experimental 2002;17(6):267-277.
  35. 35. Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. Journal of Alternative and Complementary Medicine 2000;6(3):219-229.
  36. 36. Santos RF, Galduróz JC, Barbieri A, Castiglioni ML, Ytaya LY, Bueno OF. Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using Ginkgo biloba. Pharmacopsychiatry 2003;36(4):127-133.
  37. 37. Stough C, Clarke J, Lloyd J, Nathan PJ. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. The International Journal of Neuropsychopharmacology 2001;4(2):131-134.
  38. 38. Kennedy DO, Scholey AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology 2000;151(4):416-423.
  39. 39. Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. Journal of Alternative and Complementary Medicine 2000;6(3):219-229.
  40. 40. Santos RF, Galduróz JC, Barbieri A, Castiglioni ML, Ytaya LY, Bueno OF. Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using Ginkgo biloba. Pharmacopsychiatry 2003;36(4):127-133.
  41. 41. Stough C, Clarke J, Lloyd J, Nathan PJ. Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. The International Journal of Neuropsychopharmacology 2001;4(2):131-134.
  42. 42. Kamimori GH, Penetar DM, Headley DB, Thorne DR, Otterstetter R, Belenky G. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. European Journal of Clinical Pharmacology 2000;56(8):537-544.
  43. 43. Christopher G, Sutherland D, Smith A. Effects of caffeine in non-withdrawn volunteers. Human Psychopharmacology 2005;20(1):47-53.
  44. 44. Zwyghuizen-Doorenbos A, Roehrs TA, Lipschutz L, Timms V, Roth T. Effects of caffeine on alertness. Psychopharmacology 1990;100(1):36-39.